Literature DB >> 33067381

Microglial autophagy-associated phagocytosis is essential for recovery from neuroinflammation.

Rasmus Berglund1, Andre Ortlieb Guerreiro-Cacais1, Milena Z Adzemovic1, Manuel Zeitelhofer2, Harald Lund1, Ewoud Ewing1, Sabrina Ruhrmann1, Erik Nutma3, Roham Parsa1, Melanie Thessen-Hedreul1, Sandra Amor3,4, Robert A Harris1, Tomas Olsson1, Maja Jagodic5.   

Abstract

Multiple sclerosis (MS) is a leading cause of incurable progressive disability in young adults caused by inflammation and neurodegeneration in the central nervous system (CNS). The capacity of microglia to clear tissue debris is essential for maintaining and restoring CNS homeostasis. This capacity diminishes with age, and age strongly associates with MS disease progression, although the underlying mechanisms are still largely elusive. Here, we demonstrate that the recovery from CNS inflammation in a murine model of MS is dependent on the ability of microglia to clear tissue debris. Microglia-specific deletion of the autophagy regulator Atg7, but not the canonical macroautophagy protein Ulk1, led to increased intracellular accumulation of phagocytosed myelin and progressive MS-like disease. This impairment correlated with a microglial phenotype previously associated with neurodegenerative pathologies. Moreover, Atg7-deficient microglia showed notable transcriptional and functional similarities to microglia from aged wild-type mice that were also unable to clear myelin and recover from disease. In contrast, induction of autophagy in aged mice using the disaccharide trehalose found in plants and fungi led to functional myelin clearance and disease remission. Our results demonstrate that a noncanonical form of autophagy in microglia is responsible for myelin degradation and clearance leading to recovery from MS-like disease and that boosting this process has a therapeutic potential for age-related neuroinflammatory conditions.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID: 33067381     DOI: 10.1126/sciimmunol.abb5077

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  21 in total

Review 1.  Autophagy in health and disease: From molecular mechanisms to therapeutic target.

Authors:  Guang Lu; Yu Wang; Yin Shi; Zhe Zhang; Canhua Huang; Weifeng He; Chuang Wang; Han-Ming Shen
Journal:  MedComm (2020)       Date:  2022-07-10

2.  Resveratrol Attenuated Manganese-Induced Learning and Memory Impairments in Mice Through PGC-1Alpha-Mediated Autophagy and Microglial M1/M2 Polarization.

Authors:  Jing Lang; Dongying Yan; Liang Gao; Jie Wu; Jia Meng; Xianhui Gao; Honglin Ma
Journal:  Neurochem Res       Date:  2022-07-24       Impact factor: 4.414

Review 3.  Autophagy in major human diseases.

Authors:  Daniel J Klionsky; Giulia Petroni; Ravi K Amaravadi; Eric H Baehrecke; Andrea Ballabio; Patricia Boya; José Manuel Bravo-San Pedro; Ken Cadwell; Francesco Cecconi; Augustine M K Choi; Mary E Choi; Charleen T Chu; Patrice Codogno; Maria Isabel Colombo; Ana Maria Cuervo; Vojo Deretic; Ivan Dikic; Zvulun Elazar; Eeva-Liisa Eskelinen; Gian Maria Fimia; David A Gewirtz; Douglas R Green; Malene Hansen; Marja Jäättelä; Terje Johansen; Gábor Juhász; Vassiliki Karantza; Claudine Kraft; Guido Kroemer; Nicholas T Ktistakis; Sharad Kumar; Carlos Lopez-Otin; Kay F Macleod; Frank Madeo; Jennifer Martinez; Alicia Meléndez; Noboru Mizushima; Christian Münz; Josef M Penninger; Rushika M Perera; Mauro Piacentini; Fulvio Reggiori; David C Rubinsztein; Kevin M Ryan; Junichi Sadoshima; Laura Santambrogio; Luca Scorrano; Hans-Uwe Simon; Anna Katharina Simon; Anne Simonsen; Alexandra Stolz; Nektarios Tavernarakis; Sharon A Tooze; Tamotsu Yoshimori; Junying Yuan; Zhenyu Yue; Qing Zhong; Lorenzo Galluzzi; Federico Pietrocola
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 14.012

Review 4.  Histamine and Microglia.

Authors:  Tomomitsu Iida; Kazuhiko Yanai; Takeo Yoshikawa
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 5.  Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.

Authors:  Zhiqiang Deng; Yu Dong; Xiaoting Zhou; Jia-Hong Lu; Zhenyu Yue
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

6.  Atg7 deficiency in microglia drives an altered transcriptomic profile associated with an impaired neuroinflammatory response.

Authors:  Lara Friess; Mathilde Cheray; Lily Keane; Kathleen Grabert; Bertrand Joseph
Journal:  Mol Brain       Date:  2021-06-03       Impact factor: 4.041

7.  Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading.

Authors:  Yin Xu; Nicholas E Propson; Shuqi Du; Wen Xiong; Hui Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 12.779

Review 8.  Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk.

Authors:  Gaigai Li; Prativa Sherchan; Zhouping Tang; Jiping Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 9.  Mitophagy Modulation, a New Player in the Race against ALS.

Authors:  Enrique Madruga; Inés Maestro; Ana Martínez
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

10.  Deficiency of Microglial Autophagy Increases the Density of Oligodendrocytes and Susceptibility to Severe Forms of Seizures.

Authors:  Mahabub Maraj Alam; Xiao-Feng Zhao; Yuan Liao; Ramkumar Mathur; Sarah E McCallum; Joseph E Mazurkiewicz; Matthew A Adamo; Paul Feustel; Sophie Belin; Yannick Poitelon; Xinjun Cindy Zhu; Yunfei Huang
Journal:  eNeuro       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.